Work

A Phase I/II Clinical Trial of the First-in-Class GPCR Antagonist ONC201 in Relapsed/Refractory Acute Leukemias

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.3997.3997

Authors: Gautam Borthakur, Jo Ishizawa, Courtney D DiNardo, Tapan M. Kadia, Katherine Weise, Joshua E Allen, Wolfgang Oster, Jorge E. Cortes, Hagop M. Kantarjian, Michael Andreeff

Institutions: The University of Texas MD Anderson Cancer Center, Oncoceutics (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2608836275

FWCI:

Cites:

Cited by: 1

Related to: 10